Per Artikel

Riset dan Pengabdian Masyarakat Do Research Sosial Service and Innovation

Id	Authors	Author S Id	Title	Year	Source Title	Volume	Issue	Art No	Page Start	Page End	Cited By	Link	Affiliations	Authors With Affiliations	Abstract	Author Keywords	Index Keywords	Publisher	Issn	Pubmed Id	Document Type	Sjr Best Quartile	Sjr	Sjr Rank
Display # Page 11 of 93 Start Prev 6 7 8 9 10 11 12 13 14 15 Next End
No records
101	Lazarus G., Nelwan E.J., Hamers R.L.	57214599425;14527452900;23034345900;	Transaminases and serum albumin as early predictors of severe dengue	2021	The Lancet Infectious Diseases	21	11		1488	1489		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117964341&doi=10.1016%2fS1473-3099%2821%2900583-1&partnerID=40&md5=4f1ea8000ad6ebe270b36045aad4f5b7	Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK, United Kingdom	Lazarus, G., Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Nelwan, E.J., Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia—Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Hamers, R.L., Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia, Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK, United Kingdom	[No abstract available]		aminotransferase; serum albumin; aminotransferase; serum albumin; human; Letter; meta analysis; protein blood level; severe dengue; systematic review (topic); dengue; liver function test; severe dengue; Dengue; Humans; Liver Function Tests; Serum Albumin; Severe Dengue; Transaminases	Elsevier Ltd	14733099	34717802	Letter	Q1	7475	144	View
102	Hamid A.R.A.H., Mochtar C.A., Lisnawati, Saraswati M., Matondang S., Affan M.I.F.	57202054669;6506558321;24449072000;57208472364;57192085914;57312341900;	Adenocarcinoma mucinosum of extrophy bladder: A rare case report	2021	International Journal of Surgery Case Reports	88		106493				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117928866&doi=10.1016%2fj.ijscr.2021.106493&partnerID=40&md5=1f53d31ce0245f1e48544663e50eb793	Department of Urology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia; Department of Anatomical Pathology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia; Department of Radiology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia	Hamid, A.R.A.H., Department of Urology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia; Mochtar, C.A., Department of Urology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia; Lisnawati, Department of Anatomical Pathology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia; Saraswati, M., Department of Anatomical Pathology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia; Matondang, S., Department of Radiology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia; Affan, M.I.F., Department of Urology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Indonesia	Introduction: Bladder exstrophy is a rare congenital anomaly while, bladder adenocarcinoma mucinous type is a rare type of bladder cancer, with aggressive behavior and inadequate response to radiation and chemotherapy. In extremely rare cases, untreated bladder exstrophy could transform into bladder mucinous adenocarcinoma. Case presentation: We report a case of a 41-year-old male with untreated bladder exstrophy that transformed into mucinous adenocarcinoma. The patient also had epispadias and a right inguinal hernia. Joint procedures were conducted to perform radical cystectomy, total penectomy and W-Pouch continent urostomy, inguinal hernia repair, osteotomy, and keystone and scrotal flap by split-thickness skin graft (STSG) for wound closure. The patient progressed well after surgery, two months after initial procedure, nephrostomies were conducted due to pouches stenosis. Due to the government's limited transportation and lockdown policy, as the Covid-19 pandemic occurred, the patient could not come to the hospital for routine follow-up and died nine-month after surgery. Clinical discussion: Bladder exstrophy is one of the risk factors of bladder cancer. Transformation of bladder exstrophy into mucinous adenocarcinoma is extremely rare, as the case is the first case to be discovered in Indonesia. Surgery, followed with a strict follow-up regime, is mainstay of treatment in this type of malignancy. Conclusion: Adenocarcinoma of mucinous type is a scarce type of bladder exstrophy malignancies. A multidiscipline approach is mandatory in these cases. Strict and regular follow up are suggested for these cases. © 2021 The Authors	Bladder exstrophy; Epispadias; Inguinal hernia; Mucinous adenocarcinoma	creatinine; adult; Article; bladder carcinoma; bladder exstrophy; case report; clinical article; colloid carcinoma; coronavirus disease 2019; creatinine blood level; cystectomy; echography; epispadias; excisional biopsy; hernioplasty; histopathology; human; human tissue; hydronephrosis; hydroureter; inguinal hernia; inguinal region; interstitial cystitis; lockdown; male; malignant transformation; multidisciplinary team; nephrostomy; pandemic; pelvis radiography; penis amputation; split thickness skin graft; surgical mortality; wide excision; wound closure; x-ray computed tomography	Elsevier Ltd	22102612		Article	Q3	232	17549	View
103	Yolanda S., Maharani K., Imran D., Estiasari R.	57190854113;57189235094;57203976849;55240204000;	Intractable singultus as an initial symptom of medulla oblongata tuberculoma: A rare case report	2021	Clinical Neurology and Neurosurgery	210		106989				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117726468&doi=10.1016%2fj.clineuro.2021.106989&partnerID=40&md5=941f168d079d74939effe24d3444fa1e	Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Indonesia; Department of Medical Physiology, Faculty of Medicine Universitas Indonesia, Indonesia	Yolanda, S., Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Indonesia, Department of Medical Physiology, Faculty of Medicine Universitas Indonesia, Indonesia; Maharani, K., Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Indonesia; Imran, D., Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Indonesia; Estiasari, R., Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Central General Hospital, Indonesia	Tuberculoma of medulla oblongata is a rare manifestation of central nervous system tuberculosis (CNS TB), which may manifest as intractable singultus as the initial symptom. It is almost impossible to obtain definite diagnosis through biopsy consider its location. Immediate thorough diagnostic workup is needed, and empirical treatment should be started. We report a case of medulla oblongata tuberculoma in an HIV-negative 38-year-old man with intractable singultus as one of the early symptoms. He was treated empirically with anti-tuberculosis therapy and his symptoms subsided within 2 weeks. © 2021 Elsevier B.V.	Medulla oblongata; Singultus; Tuberculoma	dexamethasone; ethambutol; isoniazid; pyrazinamide; rifampicin; tuberculostatic agent; tuberculostatic agent; adult; Article; brain cortex; case report; central nervous system tuberculosis; clinical article; coughing; drug withdrawal; fever; gastrointestinal symptom; Glasgow coma scale; headache; hiccup; human; human cell; lung tuberculosis; male; medulla oblongata; mental disease; puncture; tuberculoma; vomiting; complication; diagnostic imaging; hiccup; medulla oblongata; tuberculoma; Adult; Antitubercular Agents; Hiccup; Humans; Male; Medulla Oblongata; Tuberculoma	Elsevier B.V.	03038467	34700277	Article	Q2	587	8611	View
104	Rustamadji P., Wiyarta E., Anggraeni T.D., Siregar T.P.	55321572200;57221521342;57192894826;57222017915;	Adult granulosa cell tumor with minor foci of juvenile granulosa cell tumor in postmenopausal woman: A rare case report	2021	International Journal of Surgery Case Reports	88		106531				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117387663&doi=10.1016%2fj.ijscr.2021.106531&partnerID=40&md5=b928e465d23286856e05bfdba88bbaad	Department of Pathological Anatomy, Dr. Cipto Mangunkusumo National General Hospital, Central Jakarta, Jakarta 10430, Indonesia; Faculty of Medicine, Universitas Indonesia, Central Jakarta, Jakarta 10430, Indonesia; Department of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo National General Hospital, Central Jakarta, Jakarta 10430, Indonesia; Department of Radiology, Dr. Cipto Mangunkusumo National General Hospital, Central Jakarta, Jakarta 10430, Indonesia	Rustamadji, P., Department of Pathological Anatomy, Dr. Cipto Mangunkusumo National General Hospital, Central Jakarta, Jakarta 10430, Indonesia; Wiyarta, E., Faculty of Medicine, Universitas Indonesia, Central Jakarta, Jakarta 10430, Indonesia; Anggraeni, T.D., Department of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo National General Hospital, Central Jakarta, Jakarta 10430, Indonesia; Siregar, T.P., Department of Radiology, Dr. Cipto Mangunkusumo National General Hospital, Central Jakarta, Jakarta 10430, Indonesia	Introduction: Granulosa cell tumor (GCT) is a rare neoplasm that is divided into adult GCT (AGCT) and juvenile GCT (JGCT). Generally, a patient will only have the AGCT or JGCT subtypes. Here, we presented the first case of AGTC accompanied by focal JGTC in a postmenopausal woman. Presentation of case: A 63-year-old postmenopausal woman came with distended abdomen accompanied by postmenopausal bleeding. CT scan shows a solid mass with cystic degeneration. Laparotomy found a solid mass from the right ovary measuring 18 × 15 × 14 cm. The pathological results showed a diffuse tumor representing AGCT, accompanied by Call-Exner bodies and nuclear groove. In addition, minor foci were also found, which consist of well-defined margins tumor and follicular-like structures that resemble JGCT. The patient underwent bilateral salpingo-oophorectomy with a total hysterectomy and no recurrence in three months follow-up. Discussion: Age and clinical symptoms cannot be used as specific differentiators between AGTC and JGTC. Radiological imaging also shows a similar appearance of solid masses tumors with hemorrhagic or fibrotic changes, multilocular cystic lesions, or completely cystic tumors. The concomitant findings of JGCT and AGCT could be distinguished very carefully by anatomical pathology examination. It is crucial to differentiate AGCT from JGCT, especially to see the prognosis. Conclusion: The role of pathologists is needed in differentiating AGCT and JGCT, primarily when found simultaneously. © 2021	Granulosa cell tumor; Menopause; Ovarium tumor; Pathology; Rare case	abdominal distension; abdominal radiography; adult; adult disease; Article; ascites; bilateral salpingo-oophorectomy; cancer tissue; case report; cell proliferation; clinical article; contrast enhancement; defecation; drug use; echography; female; follow up; frozen section; granulosa cell; granulosa cell tumor; human; hysterectomy; hysteroscopy; inflammatory cell; International Federation of Gynecology and Obstetrics; juvenile granulosa cell tumor; laboratory test; laparotomy; micturition; middle aged; mitosis; mobilization; myometrium; physical examination; postmenopause; postmenopause bleeding; treatment planning; tumor volume; x-ray computed tomography	Elsevier Ltd	22102612		Article	Q3	232	17549	View
105	Akmal M.M., Pabittei D.R., Prapassaro T., Suhartono R., Moll F.L., van Herwaarden J.A.	57212520722;36722034600;57205214358;57218884615;7103009095;6602663510;	A systematic review of the current status of interventions for type II endoleak after EVAR for abdominal aortic aneurysms	2021	International Journal of Surgery	95		106138				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117194344&doi=10.1016%2fj.ijsu.2021.106138&partnerID=40&md5=04d622b377ba196029ff5e68c6be3e4c	Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands; Vascular surgery Division, Departement of Surgery, Faculty of Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Indonesia; Departement of Physiology, Hasanudin University, Indonesia; Departement of vascular surgery, Siriraj Hospital, Mahidol UniversityBangkok, Thailand	Akmal, M.M., Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands, Vascular surgery Division, Departement of Surgery, Faculty of Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Indonesia; Pabittei, D.R., Departement of Physiology, Hasanudin University, Indonesia; Prapassaro, T., Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands, Departement of vascular surgery, Siriraj Hospital, Mahidol UniversityBangkok, Thailand; Suhartono, R., Vascular surgery Division, Departement of Surgery, Faculty of Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Indonesia; Moll, F.L., Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands; van Herwaarden, J.A., Departement of vascular surgery, University Medical Center Utrecht, Utrecht, Netherlands	Objective: To study the mid- and long-term outcomes of type II endoleak treatment after EVAR and the technical aspects of different techniques to exclude endoleaks which different embolic agents. Methods: A systematic review was performed using the approach recommended by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for meta-analyses of interventional studies. The comprehensive search was conducted using the following database: MEDLINE, EMBASE, and the Cochrane Library. Patient characteristic, intervention approaches, embolic agents, and results at mid and long term follow up were studied. Results: A total of 6 studies corresponding to a total of 141 patients fulfilled the inclusion criteria with a mean age of 73–78.6 years and a mean duration of follow up varying from 25 to 42 months. There were different techniques for embolization used (translumbar, transarterial, and transcaval approach) with various types of embolic agents. In all studies, the indication for embolization of the type II endoleaks was sac enlargement of more than 5 mm. A wide range of technical success rate was reported regardless of the intervention strategy being used (17,6%–100%). The overall technical success rate of all studies was 62%. Conclusion: This systematic review shows that there is a wide variety of techniques to exclude a persistent type II endoleak. Different kinds of embolic agents have be used. Due to a lack of peer reviewed data on longterm follow-up, it was not possible to come to recommendations what treatment would be the best for a durable exclusion of a persistent type II endoleak after an initially successful EVAR. There remains an urgent need for proper executed studies, either randomized or with close observation in relation to longer follow-up. © 2021 The Authors	Abdominal aorta aneurysm; Aneurysm repair; Endoleaks; Endovascular aneurysm repair; Type	ethylene vinyl alcohol copolymer; glue; iodinated poppyseed oil; onyx copolymer; thrombin; abdominal aortic aneurysm; aged; artificial embolization; clinical outcome; cohort analysis; conservative treatment; data extraction; endoleak; endovascular aneurysm repair; follow up; human; laparoscopic surgery; major clinical study; meta analysis; outcome assessment; postoperative infection; practice guideline; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; quality control; Review; selective transcaval embolization; surgical approach; systematic review; transarterial embolization; translumbar embolization; treatment duration; treatment indication; type ii endoleak; very elderly; adverse event; artificial embolization; endoleak; endovascular surgery; Aged; Aortic Aneurysm, Abdo	Elsevier Ltd	17439191	34637951	Review	Q1	1315	2831	View
106	Tobing S.D.A.L., Hendriarto A., Wikanjaya R.	57192893142;57216821517;57211909508;	Conservative approach for treatment of Grisel's syndrome after resection of lympahadenitis tuberculosis of the neck: A rare case report	2021	International Journal of Surgery Case Reports	88		106452				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116936259&doi=10.1016%2fj.ijscr.2021.106452&partnerID=40&md5=a61504c984a695791169d7a4a2464b5f	Orthopaedic and Traumatology Department, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	Tobing, S.D.A.L., Orthopaedic and Traumatology Department, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Hendriarto, A., Orthopaedic and Traumatology Department, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Wikanjaya, R., Orthopaedic and Traumatology Department, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	Introduction: Grisel's syndrome is a rare condition characterized by nontraumatic rotatory subluxation of the atlantoaxial joint, which was caused by previous inflammation around the head and neck. It is usually seen in children and signed as torticollis. There was no consensus for management, yet early diagnosis and treatment is paramount. Presentation of case: A 5-year-old girl came to outpatient clinic complaining of wry neck 1 day after surgical excision of her TB lymphadenitis and got worsen by time. There was no history of trauma around the neck. Examination under general anesthesia and CT scan revealed acquired severe torticollis consistent with Grisel's Syndrome Fielding type 3 accompanied by TB lymphadenitis, and TB myositis of the neck. Manipulation under general anesthesia and immobilization using Minerva cast followed by Lerman Cervicothoracal Osthosis was conducted. Discussion: This patient was diagnosed with Grisel's syndrome and underwent conservative treatment consisting of reduction under general anesthesia and immobilization using Minerva cast for 6 weeks. The patient was then applied Lherman Cervical Thoracic Orthosis (CTO) halo brace for another 3 months. Anti-tuberculous drug was given to control tuberculous infection. Eight months follow-up showed neither residual deformity, neck pain, nor movement limitation of the neck. Conclusion: Grisel's syndrome has excellent result that is treated with conservative treatment using reduction under general anesthesia and Minerva cast. © 2021 The Authors	Acquired torticollis; Conservative; Grisel's syndrome; Minerva cast	cobamamide; cyproheptadine; tuberculostatic agent; Article; atlantoaxial subluxation; body weight gain; case report; cervical lymph node; child; clinical article; computer assisted tomography; conservative treatment; disease exacerbation; excision; excisional biopsy; female; fever; follow up; general anesthesia; Grisel syndrome; headache; histopathology; hoarseness; human; human tissue; immobilization; infection control; interferon gamma release assay; Langhans giant cell; loss of appetite; lymphadenitis; myositis; nausea; neck malformation; neuroimaging; night sweat; nuclear magnetic resonance imaging; outpatient department; physical examination; preschool child; puncture; range of motion; sternocleidomastoid muscle; torticollis; tuberculin test; tuberculous lymphadenitis	Elsevier Ltd	22102612		Article	Q3	232	17549	View
107	Poerbonegoro N.L., Reksodiputro M.H., Sari D.P., Mufida T., Rahman M.A., Reksodiputro L.A., Audindra S., Yosia M.	57222574894;35090488800;57292553600;57291865900;57291413400;57292781100;57222006228;57204933098;	Cross-sectional study on the proportion of smell and taste disturbances in hospitalized COVID-19 patients	2021	Annals of Medicine and Surgery	71		102909				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116899241&doi=10.1016%2fj.amsu.2021.102909&partnerID=40&md5=96e678393268c92055e16d284f8c40f7	Otorhinolaryngology-Head Neck Surgery Medical Staff Group, Universitas Indonesia Hospital, Depok, West Java, Indonesia; Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia	Poerbonegoro, N.L., Otorhinolaryngology-Head Neck Surgery Medical Staff Group, Universitas Indonesia Hospital, Depok, West Java, Indonesia; Reksodiputro, M.H., Otorhinolaryngology-Head Neck Surgery Medical Staff Group, Universitas Indonesia Hospital, Depok, West Java, Indonesia; Sari, D.P., Otorhinolaryngology-Head Neck Surgery Medical Staff Group, Universitas Indonesia Hospital, Depok, West Java, Indonesia; Mufida, T., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Rahman, M.A., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Reksodiputro, L.A., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Audindra, S., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Yosia, M., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia	Background: The number of confirmed Coronavirus Disease-2019 (COVID-19) cases in Indonesia had reached 1.4 million cases from a total population of 270 million. Smell and/or taste disturbances are frequently found as early symptoms of COVID-19 patients. Our study aimed to investigate the proportion and characteristics of anosmia and/or ageusia in COVID-19. Materials and methods: This cross-sectional study identifies the proportion and severity of smell and taste disturbances in COVID-19 patients. Subjects were recruited by consecutive sampling. All subjects were required to fill in the questionnaire modified from the American Academy of Otolaryngology-Head and Neck Surgery Anosmia Reporting Tool (AAO-HNS ART). Symptoms severity was measured with a numerical rating scale of 0–10; 0–3 is defined as mild, 4–6 as moderate, and 7–10 as severe. Results: Out of 51 subjects, 34 (66.7%) suffered from smell and/or taste disturbances. Twenty-nine of 34 subjects (85.3%) suffered from smell disturbance, and 24 of 34 subjects (70.5%) suffered from taste disturbance. Severe smell disturbance occurred in 68.9% of subjects, while severe taste disturbance occurred in 50%. The median onset was three days for smell disturbance and four days for taste disturbance after any symptoms of COVID-19. Conclusion: Smell and/or taste disturbances were early symptoms of COVID-19. These symptoms commonly occurred within the first four days of clinical onset and frequently manifested in severe conditions. © 2021	Ageusia; Anosmia; COVID-19; Indonesia	adult; American Academy of Otolaryngology Head and Neck Surgery Anosmia Reporting Tool; Article; coronavirus disease 2019; cross-sectional study; disease assessment; disease severity; female; human; major clinical study; male; numeric rating scale; questionnaire; real time polymerase chain reaction; retrospective study; risk factor; smelling disorder; taste disorder; visual analog scale	Elsevier Ltd	20490801		Article	Q3	391	12334	View
108	Liberty I.A., Kodim N., Sartika R.A.D., Trihandini I., Tjekyan R.M.S., Zulkarnain, Pane M., Pratisthita L.B., Tahapary D.L., Soewondo P.	57211435130;57210444174;41862490800;8449988100;57267287700;57267073300;55831164800;57221504201;55944492500;23475336100;	Triglyceride/Glucose Index (TyG Index) as a marker of glucose status conversion among reproductive-aged women in Jakarta, Indonesia: The Bogor cohort study (2011–2016)	2021	Diabetes and Metabolic Syndrome: Clinical Research and Reviews	15	6	102280				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115349587&doi=10.1016%2fj.dsx.2021.102280&partnerID=40&md5=db55d7f5dcad157ad5a355acd19a0c89	Department of Public Health and Community Medicine, University of Sriwijaya, Indonesia; Department of Epidemiology, Public Health Faculty, Universitas Indonesia, Depok, Indonesia; Department of Public Nutrition, Public Health Faculty Universitas Indonesia, Depok, Indonesia; Department of Biostatistics, Public Health Faculty Universitas Indonesia, Depok, Indonesia; National Institute Health Research and Development, Ministry of Health of the Republic of Indonesia, Indonesia; Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Department of Internal Medicine, Universitas Indonesia Hospital, Depok, Indonesia; Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia	Liberty, I.A., Department of Public Health and Community Medicine, University of Sriwijaya, Indonesia, Department of Epidemiology, Public Health Faculty, Universitas Indonesia, Depok, Indonesia; Kodim, N., Department of Epidemiology, Public Health Faculty, Universitas Indonesia, Depok, Indonesia; Sartika, R.A.D., Department of Public Nutrition, Public Health Faculty Universitas Indonesia, Depok, Indonesia; Trihandini, I., Department of Biostatistics, Public Health Faculty Universitas Indonesia, Depok, Indonesia; Tjekyan, R.M.S., Department of Public Health and Community Medicine, University of Sriwijaya, Indonesia; Zulkarnain, Department of Public Health and Community Medicine, University of Sriwijaya, Indonesia; Pane, M., National Institute Health Research and Development, Ministry of Health of the Republic of Indonesia, Indonesia; Pratisthita, L.B., Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Department of Internal Medicine, Universitas Indonesia Hospital, Depok, Indonesia; Tahapary, D.L., Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Soewondo, P., Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia	Background and aims: Reproductive-aged women are prone to type 2 diabetes mellitus. This study aims to evaluate the optimal cut off point of Triglyceride/Glucose Index for predicting glucose status conversion among women of reproductive age. Methods: This study involved normoglycemic and prediabetes women aged 20–49 years from the Bogor Non-Communicable Diseases Cohort Study (West Java, Indonesia) conducted from 2011 to 2016. Statistical analysis was performed using Receiver Operating Characteristics curve analysis with STATA version 15. Results: Among prediabetes subjects (n = 371), the cut-off point of TyG index for regression from prediabetes to normoglycemic subjects was <4.51 [sensitivity, specificity, AUC (95%CI) 83.9%, 80.1%, 0.913 (0.875–0.943), respectively] and the cut-off point for progression from prediabetes to diabetes was >4.54 [80.0%, 73.1%, 0.858 (0.807–0.900)]. Among normoglycemic subjects (n = 1300), the cut-off point of TyG index for progression to prediabetes and diabetes were >4.44 [80.1%, 71.1%, 0.834 (0.812–0.854)] and >4.47 [80.6%, 80.8%, 0.909 (0.890–0.926)] respectively. Conclusion: Based on sample of subjects evaluated between 2011 and 2016, TyG index appears to be a promising marker for glucose status conversion among reproductive-aged women in Jakarta, Indonesia. © 2021	Conversion; Glucose; Reproductive; TyG index; Women	biological marker; cholesterol; glucose; hemoglobin A1c; high density lipoprotein cholesterol; low density lipoprotein cholesterol; triacylglycerol; adult; Article; cholesterol blood level; cohort analysis; controlled study; data analysis software; diabetes mellitus; evaluation study; female; follow up; glucose blood level; groups by age; human; impaired glucose tolerance; Indonesia; major clinical study; middle aged; oral glucose tolerance test; outcome assessment; predictive value; receiver operating characteristic; reference value; remission; reproduction; retrospective study; sensitivity and specificity; statistical analysis; triacylglycerol blood level; triglyceride glucose index; young adult	Elsevier Ltd	18714021	34562866	Article	Q2	684	7304	View
109	Patelis N., Bisdas T., Jing Z., Feng J., Trenner M., Tri Nugroho N., Ocke Reis P.E., Elkouri S., Lecis A., Karam L., Roux D.L., Ionac M., Berczeli M., Jongkind V., Yeung K.K., Katsargyris A., Avgerinos E., Moris D., Choong A., Ng J.J., Cvjetko I., Antoniou G.A., Ghibu P., Svetlikov A., Pedrajas F.G., Ebben H., Stepak H., Chornuy A., Kostiv S., Ancetti S., Tadayon N., Mekkar A., Magnitskiy L., Fidalgo-Domingos L., Matheiken S., Sarutte Rosello E.S., Isik A., Kirkilesis G., Kakavia K., Georgopoulos S.	55998488300;33467522500;57262125800;57261537000;56798307500;57211452795;57261833800;6604020673;55309720700;36504221700;57261537100;57262413400;57204192771;22937335300;15926593800;15923092600;6701829526;39661222400;57217303517;57226512691;7801457268;36086125600;57261833900;6508177128;6504474654;56115588600;55760251500;57262413500;57222182796;56703428400;35182045900;57261687200;57262413600;57197759620;36834063300;57261982900;57159146500;56201755100;57191724932;7003934555;	Vascular e-Learning During the COVID-19 Pandemic: The EL-COVID Survey	2021	Annals of Vascular Surgery	77			63	70	1	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115056401&doi=10.1016%2fj.avsg.2021.08.001&partnerID=40&md5=f50ec7bdac85163ad44fb75c200c67b8	Third Department of Vascular Surgery, Athens Medical Center, Greece; National & Kapodistrian University of Athens, Greece; Vascular surgery department, First affiliated hospital to Navy medical universityShanghai, China; Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Germany; Faculty of Medicine University of Indonesia - Cipto Mangunkusumo National Hospital, Indonesia; Federal University Fluminense, Brazil; Centre Hospitalier de l'Université de Montréal, Canada; Centre Hospitalier de Troyes, France; Hotel Dieu de France Hospital, Lebanon; University of the Witwatersrand, South Africa; University of Medicine and Pharmacy, Romania; Semmelweis University, Hungary; Amsterdam University Medical Center, Netherlands; VU Medical Center, Netherlands; Paracelsus Medical University, Klinikum Nurenberg, Germany; University of Pittsburgh Medical Center, United States; Duke University Medical Center, United States; National University of Singapore, Singapore; University Hospital Merkur, Croatia; Pennine Acute Hospitals NHS TrustUK, United Kingdom; University Hospital HairmyresUK, United Kingdom; Vascular & endovascular surgery Center, National Scientific-Clinical Memorial Hospital, "Professor I.I. Mechnikov", North-Western Medical University, Russian Federation; Hospital Quironsalud Málaga, Spain; Poznan University of Medical Sciences, Poland; Ternopil University Clinic, Ukraine; University of Bologna, Italy; Shahid Beheshti University of Medical Sciences, Iran; CHU Titi Ouzou, Algeria; Pirogov City Hospital No1, Russian Federation; Hospital Clínico Universitario de Valladolid, Spain; Bedford Hospital NHS TrustUK, United Kingdom; Universidad de la Republica, Uruguay; Erzincan Binali Yildirim University, Turkey	Patelis, N., Third Department of Vascular Surgery, Athens Medical Center, Greece, National & Kapodistrian University of Athens, Greece; Bisdas, T., Third Department of Vascular Surgery, Athens Medical Center, Greece; Jing, Z., Vascular surgery department, First affiliated hospital to Navy medical universityShanghai, China; Feng, J., Vascular surgery department, First affiliated hospital to Navy medical universityShanghai, China; Trenner, M., Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Germany; Tri Nugroho, N., Faculty of Medicine University of Indonesia - Cipto Mangunkusumo National Hospital, Indonesia; Ocke Reis, P.E., Federal University Fluminense, Brazil; Elkouri, S., Centre Hospitalier de l'Université de Montréal, Canada; Lecis, A., Centre Hospitalier de Troyes, France; Karam, L., Hotel Dieu de France Hospital, Lebanon; Roux, D.L., University of the Witwatersrand, South Africa; Ionac, M., University of Medicine and Pharmacy, Romania; Berczeli, M., Semmelweis University, Hungary; Jongkind, V., Amsterdam University Medical Center, Netherlands; Yeung, K.K., VU Medical Center, Netherlands; Katsargyris, A., National & Kapodistrian University of Athens, Greece, Paracelsus Medical University, Klinikum Nurenberg, Germany; Avgerinos, E., National & Kapodistrian University of Athens, Greece, University of Pittsburgh Medical Center, United States; Moris, D., Duke University Medical Center, United States; Choong, A., National University of Singapore, Singapore; Ng, J.J., National University of Singapore, Singapore; Cvjetko, I., University Hospital Merkur, Croatia; Antoniou, G.A., Pennine Acute Hospitals NHS TrustUK, United Kingdom; Ghibu, P., University Hospital HairmyresUK, United Kingdom; Svetlikov, A., Vascular & endovascular surgery Center, National Scientific-Clinical Memorial Hospital, "Professor I.I. Mechnikov", North-Western Medical University, Russian Federation; Pedrajas, F.G., Hospital Quironsalud Málaga, Spain; Ebben, H., Semmelweis University, Hungary; Stepak, H., Poznan University of Medical Sciences, Poland; Chornuy, A., Ternopil University Clinic, Ukraine; Kostiv, S., Ternopil University Clinic, Ukraine; Ancetti, S., University of Bologna, Italy; Tadayon, N., Shahid Beheshti University of Medical Sciences, Iran; Mekkar, A., CHU Titi Ouzou, Algeria; Magnitskiy, L., Pirogov City Hospital No1, Russian Federation; Fidalgo-Domingos, L., Hospital Clínico Universitario de Valladolid, Spain; Matheiken, S., Bedford Hospital NHS TrustUK, United Kingdom; Sarutte Rosello, E.S., Universidad de la Republica, Uruguay; Isik, A., Erzincan Binali Yildirim University, Turkey; Kirkilesis, G., National & Kapodistrian University of Athens, Greece; Kakavia, K., National & Kapodistrian University of Athens, Greece; Georgopoulos, S., National & Kapodistrian University of Athens, Greece	Background: The corona virus disease (COVID-19) pandemic has radically changed the possibilities for vascular surgeons and trainees to exchange knowledge and experience. The aim of the present survey is to inventorize the e-learning needs of vascular surgeons and trainees as well as the strengths and weaknesses of vascular e-Learning. Methods: An online survey consisting of 18 questions was created in English, with a separate bilingual English-Mandarin version. The survey was dispersed to vascular surgeons and trainees worldwide through social media and via direct messaging from June 15, 2020 to October 15, 2020. Results: Eight hundred and fifty-six records from 84 different countries could be included. Most participants attended several online activities (>4: n = 461, 54%; 2–4: n = 300, 35%; 1: n = 95, 11%) and evaluated online activities as positive or very positive (84.7%). In deciding upon participation, the topic of the activity was most important (n = 440, 51.4%), followed by the reputation of the presenter or the panel (n = 178, 20.8%), but not necessarily receiving accreditation or certification (n = 52, 6.1%). The survey identified several shortcomings in vascular e-Learning during the pandemic: limited possibility to attend due to lack of time and increased workload (n = 432, 50.5%), no protected/allocated time (n = 488, 57%) and no accreditation or certification, while technical shortcomings were only a minor problem (n = 25, 2.9%). Conclusions: During the COVID-19 pandemic vascular e-Learning has been used frequently and was appreciated by vascular professionals from around the globe. The survey identified strengths and weaknesses in current e-Learning that can be used to further improve online learning in vascular surgery. © 2021		accreditation; Article; certification; controlled study; coronavirus disease 2019; distance learning; e-learning; English (language); geographic distribution; health survey; human; information dissemination; Internet; Mandarin (language); pandemic; social media; surgical training; vascular surgeon; vascular surgery; workload; workplace; clinical trial; comorbidity; education; follow up; learning; medical education; multicenter study; pandemic; procedures; questionnaire; retrospective study; surgery; teaching; vascular disease; vascular surgery; Comorbidity; Computer-Assisted Instruction; COVID-19; Education, Medical, Graduate; Follow-Up Studies; Humans; Learning; Pandemics; Retrospective Studies; SARS-CoV-2; Specialties, Surgical; Surveys and Questionnaires; Vascular Diseases; Vascular Sur	Elsevier Inc.	08905096	34478845	Article	Q2	635	7940	View
110	Abdullah M., Sukartini N., Nursyirwan S.A., Pribadi R.R., Maulahela H., Utari A.P., Muzellina V.N., Wiraatmadja A., Renaldi K.	7103393434;6505680329;57249143800;57194732282;57189612709;57113585900;57223968527;57249709700;57190963547;	Gut Microbiota Profiles in Early-and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future	2021	Digestion	102	6		823	832	1	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114428104&doi=10.1159%2f000516689&partnerID=40&md5=b8c0c7b633dbb180aa40d5f20e5481d7	Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Human Cancer Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Clinical Pathology, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia	Abdullah, M., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia, Human Cancer Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Sukartini, N., Department of Clinical Pathology, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Nursyirwan, S.A., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Pribadi, R.R., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Maulahela, H., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Utari, A.P., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Muzellina, V.N., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Wiraatmadja, A., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Renaldi, K., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia	Background: Researchers believe the role of gut microbiota dysbiosis in the raised incidence of early-onset colorectal cancer (EOCRC). The development of EOCRC may be associated with microbiota dysbiosis either dependently or independently (combined with other risk factors). Summary: Recently, the rising of incidence and mortality of EOCRC have been noted. Some researchers are looking for risk factors influencing this fact. They hypothesize that it may be because of microbiota dysbiosis. Microbiota dysbiosis has been known to promote cancer development through immunity dysregulation and chronic inflammation. Microbiomes profile in late-onset colorectal cancer (LOCRC) among older patients has been documented, but there is still lack of data about microbial profiles among younger colorectal cancer (CRC) patients. This review tries to explain microbial profiles differences between EOCRC and LOCRC as a potential diagnostic biomarker in the future, and whether microbiota can have a role in EOCRC genesis. Key Messages: Microbiota does vary with age, and EOCRC may be associated with colonization of some specific bacteria. Further studies about gut microbiota profiles in EOCRC and LOCRC may provide a new insight on diagnostic biomarker of CRC. © 2021 S. Karger AG, Basel. Copyright: All rights reserved.	Colorectal cancer; Diagnostic biomarker; Early-onset colorectal cancer; Gut microbiota; Microbiota dysbiosis	biological marker; colorectal tumor; dysbiosis; human; incidence; intestine flora; Biomarkers; Colorectal Neoplasms; Dysbiosis; Gastrointestinal Microbiome; Humans; Incidence	S. Karger AG	00122823	34433172	Review	Q2	882	5279	View

Publikasi Scopus 926 artikel (Per 14 Maret 2022)